PYY plays a key role in the resolution of diabetes following bariatric surgery in humans
Author(s) -
Claudia Guida,
Sam D. Stephen,
Michael Watson,
Niall Dempster,
Pierre Larraufie,
Thomas Marjot,
Tamsin Cargill,
Lisa Rickers,
Michael Pavlides,
Jeremy Tomlinson,
Jeremy Cobbold,
ChunMei Zhao,
Duan Chen,
Fiona M. Gribble,
Frank Reimann,
Richard Gillies,
Bruno Sgromo,
Patrik Rorsman,
John Ryan,
Reshma Ramracheya
Publication year - 2019
Publication title -
ebiomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.596
H-Index - 63
ISSN - 2352-3964
DOI - 10.1016/j.ebiom.2018.12.040
Subject(s) - medicine , endocrinology , peptide yy , islet , enteroendocrine cell , hormone , insulin , type 2 diabetes , diabetes mellitus , appetite , endocrine system , neuropeptide y receptor , receptor , neuropeptide
Bariatric surgery leads to early and long-lasting remission of type 2 diabetes (T2D). However, the mechanisms behind this phenomenon remain unclear. Among several factors, gut hormones are thought to be crucial mediators of this effect. Unlike GLP-1, the role of the hormone peptide tyrosine tyrosine (PYY) in bariatric surgery in humans has been limited to appetite regulation and its impact on pancreatic islet secretory function and glucose metabolism remains under-studied.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom